References
- Aristotle. Historia animalium. VII.5.585a
- Longcope C, Jaffee W, Griffing G. Metabolic clearance rates of androgens and oestrogens in ageing women. Maturitas 1980; 2(4) 1283–90
- Longcope C, Jaffee W, Griffing G. Production rates of androgens and oestrogens in post-menopausal women. Maturitas 1981; 3(3–4): 215–23
- Slemenda CW, Hui SL, Longcope C, et al. Predictors of bone mass in perimenopausal women: a prospective study of clinical data using photon absorptiometry. Ann Intern Med 1990; 112(2): 96–101
- Riggs BL, Wahner HW, Melton LJ 3d, et al. Rates of bone loss in the appendicular and axial skeletons of women: evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986; 77(5): 1487–91
- Schiff I, Regestein Q, Tulchinsky D, et al. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 1979; 242(22): 2405–7
- Rekers, Drogendijk AC, Valkenburg HA, et al. The menopause, urinary incontinence and other symptoms of the genito-urinary tract. Maturitas 1992; 15(2): 101–11
- Versi E. Incontinence in the climacteric. Clin Obstet Gynecol 1990; 33(2): 392–8
- Brincat M, Yuen AW, Studd JW, et al. Response of skin thickness and metacarpal index to estradiol therapy in postmenopausal women. Obstet Gynecol 1987; 70(4): 538–41
- Kiel DP, Felson DT, Anderson JJ, et al. Hip fracture and the use of estrogens in postmenopausal women: the Framingham Study. N Engl J Med 1987; 317(19): 1169–74
- Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993; 328(7): 460–4
- Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 1987; 316(4): 173–7
- Quigley ME, Martin PL, Burnier AM, et al. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987; 156(6): 1516–23
- Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986: 111(2): 383–90
- Chetkowski RJ, Meldrum DR, Steingold KA, et al. Biologic effects of transdermal estradiol. N Engl J Med 1986; 314(25): 1615–20
- Sack MN, Rader DJ, Cannon RO 3d. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994; 343(8892): 269–70
- Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325(11): 756–62
- Nabulsi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328(15): 1069–75
- Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991: 20(1): 47–63
- Gambrell RD Jr. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertil Steril 1982; 37(4): 457–74
- Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265 (15): 1985–90 [Erratum, JAMA 1991; 266(10): 1362]
- Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151(1): 67–72
- Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989: 149(11): 2445–8
- Schachter B, Marrian GF. The isolation of estrone sulfate from the urine of pregnant mares. J Biol Chem 1938; 126: 663–70
- Leather AT, Savvas M, Studd JW. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women. Obstet Gynecol 1991; 78(6): 1008–10
- Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Intern Med 1989; 149(1): 133–6